Wegovy could potentially prevent Covid-19 deaths, study shows
Coronavirus
In This Story NVO A new analysis of a clinical trial of semaglutide — the active ingredient in Wegovy — showed that the popular weight loss drug reduced the risk of Covid-19 deaths among patients with heart disease. Suggested Reading Shell has decided it's not so eager to look for oil these days Typhoon Shanshan is blowing planes off the runway in Japan This vaccine stock surged after the FDA cleared it for mpox Kamala Harris' grocery price gouging ban? No economist on earth will support it,
din zilele anterioare